24 hour mean SBP ≥ 130 mmHg by cuffless ambulatory BP monitor
aged ≥30 and \<80 years
voluntarily decide to participate in this clinical trial and provide written informed consent after being adequately informed.
willing and able to comply with the requirements of the study protocol
You may not be if
Did not agree with this clinical trial and did not provide informed consent
Office SBP ≥ 190 mmHg, or diastolic BP (DBP) \< 60 mmHg.
Diagnosed secondary hypertension.
Hospitalization for stroke, myocardial infarction (MI) or unstable angina within the last 6 months
Coronary revascularization (percutaneous coronary intervention \[PCI\] or coronary artery bypass grafting \[CABG\]) within the last 12 months.
Planned to perform coronary revascularization (PCI or CABG) in the next 12 months.
History of sustained atrial fibrillation (AF) or ventricular arrhythmias at entry influencing the BP measurement of ring-type cuffless BP monitoring device.
Severe valvular disease or valvular disease likely to require surgery or percutaneous valve replacement during the trial.
